0001613103-20-000029.txt : 20200901 0001613103-20-000029.hdr.sgml : 20200901 20200901171340 ACCESSION NUMBER: 0001613103-20-000029 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200901 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 201155069 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20200901.htm 8-K mdt-20200901
0001613103Medtronic plcD02 XH02false00016131032020-09-012020-09-010001613103us-gaap:CommonStockMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2021FloatingMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2021Member2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2022Member2020-09-012020-09-010001613103mdt:SeniorNotes2019Due20230.375PercentMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2025Member2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2027Member2020-09-012020-09-010001613103mdt:SeniorNotes2019Due20311.625PercentMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due20311.00PercentMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due20392.250PercentMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due20391.50PercentMember2020-09-012020-09-010001613103mdt:SeniorNotes2019Due2049Member2020-09-012020-09-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 1, 2020
 _____________________________ 
Medtronic Public Limited Company
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange
Floating Rate Notes due 2021MDT/21New York Stock Exchange
0.000% Senior Notes due 2021MDT/21ANew York Stock Exchange
0.000% Senior Notes due 2022MDT/22BNew York Stock Exchange
0.375% Senior Notes due 2023MDT/23BNew York Stock Exchange
0.25% Senior Notes due 2025MDT/25New York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.00% Senior Notes due 2031MDT/31ANew York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.50% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.75% Senior Notes due 2049MDT/49New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






Item 7.01
Regulation FD Disclosure

Medtronic today announced that it is implementing a new operating model designed to make the company a more nimble and competitive organization focused on accelerating innovation, enhancing the customer experience, driving revenue growth, and winning market share, while at the same time more efficiently and effectively leveraging its enterprise scale. This new operating model will simplify Medtronic’s organizational structure and accelerate decision-making and execution. These changes will be supported by incentives and rewards aligned to the operating model and its objectives.

Focused, Accountable, and Empowered Operating Units

Medtronic is reorganizing its current Groups to create highly focused, accountable, and empowered Operating Units (OUs), each formed from Medtronic’s existing businesses and organized around specific therapy areas. The OUs are designed to move the company even closer to its customers and to increase the agility, speed, and efficiency of the organization. Under the new operating model, OU leaders will have decision-making authority and full responsibility and accountability for their individual businesses and markets to fuel innovation, accelerate growth, and win in the marketplace. Specifically, OU leaders will have full P&L responsibility, control their own product development and clinical resources, and direct their own sales organizations in the company’s larger geographies.

Leveraging the Enterprise Scale, Expertise, and Resources

Medtronic is consolidating Operations at the enterprise level – including the company’s global manufacturing, supply chain and facilities – to provide greater service to the new, empowered OUs and better leverage the company’s enterprise scale to realize greater efficiencies and capitalize on its global reach.

Medtronic will also establish Technology Development Centers (TDCs) in areas where the company has deep core technology competencies that are leveraged by multiple OUs. While R&D resources will be primarily embedded within the OUs, TDCs will focus on continuous development and efficient sharing of advanced technologies and capabilities across OUs to accelerate innovation and supplement product development efforts.

In larger geographies around the world, Medtronic’s regions will help coordinate sales activity with the company’s largest customers across OUs. And, in smaller geographies, including many emerging markets, Medtronic’s regions will form dedicated sales organizations that leverage the company’s scale, but move with the same agility as its smaller, local competitors.

Effective Date

The company will transition to this new model beginning in its fiscal third quarter and will be fully effective at the start of its fourth quarter of fiscal year 2021. The company is also currently assessing the impact of these changes to the external reporting of its segments and will provide an update, if changes are necessary, prior to the start of its fiscal fourth quarter.

Simplification Restructuring Program

As a result of these changes, the company is initiating a Simplification Restructuring Program, which is expected to incur total pre-tax costs of approximately $400 - $450 million, the majority to be recognized by the end of fiscal year 2022. The Program is expected to result in cost savings starting this fiscal year, with annualized ongoing cost savings of approximately $450 - $475 million realized by fiscal year 2023, designed to enable reinvestment to drive future revenue growth and to strengthen the company’s ability to deliver strong long-term earnings per share growth.

Upcoming Investor Day

Medtronic management plans to discuss its new operating model at its upcoming Investor Day, to be held virtually on October 14, 2020.







In accordance with General Instruction B-2 of Form 8-K, the information set forth in or incorporated by reference into this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to, statements relating to expectations regarding anticipated costs, charges or benefits in connection with the Simplification Restructuring Program, any estimates of anticipated annual savings and allocation of expenses or charges, expectations regarding the Company’s long-term growth and efficiency, the efficacy or efficiency of any operational or management structures currently in place or which we may implement in the future, the impact COVID-19 has had and is expected to continue to have on our business, operations and production, as well as demand for our offerings, and on our employees, medical professional and the healthcare system, communities in which we operate, and our financial results and condition, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company’s periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “looking ahead,” “may,” “plan,” “possible,” “potential,” “project,” “should,” “will,” and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this Current Report on Form 8-K, including to reflect future events or circumstances.








SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   MEDTRONIC PUBLIC LIMITED COMPANY
Date: September 1, 2020   By /s/ Karen L. Parkhill
   Karen L. Parkhill
   
Executive Vice President and Chief Financial Officer





EX-101.SCH 2 mdt-20200901.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 mdt-20200901_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 mdt-20200901_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 mdt-20200901_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town 0.000% Senior Notes due 2021 Senior Notes 2019 Due 2021 [Member] Senior Notes 2019 Due 2021 [Member] Entities [Table] Entities [Table] 1.50% Senior Notes due 2039 Senior Notes 2019 Due 2039, 1.50 Percent [Member] Senior Notes 2019 Due 2039, 1.50 Percent [Member] Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type 0.375% Senior Notes due 2023 Senior Notes 2019 Due 2023, 0.375 Percent [Member] Senior Notes 2019 Due 2023, 0.375 Percent [Member] Entity Emerging Growth Company Entity Emerging Growth Company 1.75% Senior Notes due 2049 Senior Notes 2019 Due 2049 [Member] Senior Notes 2019 Due 2049 [Member] Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Trading Symbol Trading Symbol Floating Rate Notes due 2021 Senior Notes 2019 Due 2021, Floating [Member] Senior Notes 2019 Due 2021, Floating [Member] Document Period End Date Document Period End Date Entity Information [Line Items] Entity Information [Line Items] Entity Registrant Name Entity Registrant Name Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Ordinary shares, par value $0.0001 per share Common Stock [Member] Class of Stock [Axis] Class of Stock [Axis] 0.25% Senior Notes due 2025 Senior Notes 2019 Due 2025 [Member] Senior Notes 2019 Due 2025 [Member] Entity Address, Country Entity Address, Country 1.00% Senior Notes due 2031 Senior Notes 2019 Due 2031, 1.00 Percent [Member] Senior Notes 2019 Due 2031, 1.00 Percent [Member] 1.625% Senior Notes due 2031 Senior Notes 2019 Due 2031, 1.625 Percent [Member] Senior Notes 2019 Due 2031, 1.625 Percent [Member] Local Phone Number Local Phone Number 2.250% Senior Notes due 2039 Senior Notes 2019 Due 2039, 2.250 Percent [Member] Senior Notes 2019 Due 2039, 2.250 Percent [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code 0.000% Senior Notes due 2022 Senior Notes 2019 Due 2022 [Member] Senior Notes 2019 Due 2022 [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Class of Stock [Domain] Class of Stock [Domain] 1.125% Senior Notes due 2027 Senior Notes 2019 Due 2027 [Member] Senior Notes 2019 Due 2027 [Member] Country Region Country Region EX-101.PRE 6 mdt-20200901_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 mdt-20200901_htm.xml IDEA: XBRL DOCUMENT 0001613103 2020-09-01 2020-09-01 0001613103 us-gaap:CommonStockMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2021FloatingMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2021Member 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2022Member 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due20230.375PercentMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2025Member 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2027Member 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2020-09-01 2020-09-01 0001613103 mdt:SeniorNotes2019Due2049Member 2020-09-01 2020-09-01 0001613103 Medtronic plc D02 XH02 false 8-K 2020-09-01 L2 1-36820 98-1183488 20 On Hatch, Lower Hatch Street Dublin 2 IE 353 1 438-1700 false false false false Ordinary shares, par value $0.0001 per share MDT NYSE Floating Rate Notes due 2021 MDT/21 NYSE 0.000% Senior Notes due 2021 MDT/21A NYSE 0.000% Senior Notes due 2022 MDT/22B NYSE 0.375% Senior Notes due 2023 MDT/23B NYSE 0.25% Senior Notes due 2025 MDT/25 NYSE 1.125% Senior Notes due 2027 MDT/27 NYSE 1.625% Senior Notes due 2031 MDT/31 NYSE 1.00% Senior Notes due 2031 MDT/31A NYSE 2.250% Senior Notes due 2039 MDT/39A NYSE 1.50% Senior Notes due 2039 MDT/39B NYSE 1.75% Senior Notes due 2049 MDT/49 NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document And Entity Information
Sep. 01, 2020
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Sep. 01, 2020
Entity Registrant Name Medtronic plc
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One 20 On Hatch, Lower Hatch Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code D02 XH02
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001613103
Ordinary shares, par value $0.0001 per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary shares, par value $0.0001 per share
Trading Symbol MDT
Security Exchange Name NYSE
Floating Rate Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security Floating Rate Notes due 2021
Trading Symbol MDT/21
Security Exchange Name NYSE
0.000% Senior Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2021
Trading Symbol MDT/21A
Security Exchange Name NYSE
0.000% Senior Notes due 2022  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2022
Trading Symbol MDT/22B
Security Exchange Name NYSE
0.375% Senior Notes due 2023  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2023
Trading Symbol MDT/23B
Security Exchange Name NYSE
0.25% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.25% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.00% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.00% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.50% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.50% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.75% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.75% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 13 96 1 false 12 0 false 0 false false R1.htm 0001001 - Document - Document And Entity Information Sheet http://www.medtronic.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports mdt-20200901.htm mdt-20200901.xsd mdt-20200901_cal.xml mdt-20200901_def.xml mdt-20200901_lab.xml mdt-20200901_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mdt-20200901.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 13, "dts": { "calculationLink": { "local": [ "mdt-20200901_cal.xml" ] }, "definitionLink": { "local": [ "mdt-20200901_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "mdt-20200901.htm" ] }, "labelLink": { "local": [ "mdt-20200901_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mdt-20200901_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mdt-20200901.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 40, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 4 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 11, "memberStandard": 1, "nsprefix": "mdt", "nsuri": "http://www.medtronic.com/20200901", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mdt-20200901.htm", "contextRef": "i3518bc97d39744469f6b7d26ebbc6fe7_D20200901-20200901", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document And Entity Information", "role": "http://www.medtronic.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mdt-20200901.htm", "contextRef": "i3518bc97d39744469f6b7d26ebbc6fe7_D20200901-20200901", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 12, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "mdt_SeniorNotes2019Due2021FloatingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2021, Floating [Member]", "label": "Senior Notes 2019 Due 2021, Floating [Member]", "terseLabel": "Floating Rate Notes due 2021" } } }, "localname": "SeniorNotes2019Due2021FloatingMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2021 [Member]", "label": "Senior Notes 2019 Due 2021 [Member]", "terseLabel": "0.000% Senior Notes due 2021" } } }, "localname": "SeniorNotes2019Due2021Member", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2022 [Member]", "label": "Senior Notes 2019 Due 2022 [Member]", "terseLabel": "0.000% Senior Notes due 2022" } } }, "localname": "SeniorNotes2019Due2022Member", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20230.375PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]", "label": "Senior Notes 2019 Due 2023, 0.375 Percent [Member]", "terseLabel": "0.375% Senior Notes due 2023" } } }, "localname": "SeniorNotes2019Due20230.375PercentMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2025 [Member]", "label": "Senior Notes 2019 Due 2025 [Member]", "terseLabel": "0.25% Senior Notes due 2025" } } }, "localname": "SeniorNotes2019Due2025Member", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2027 [Member]", "label": "Senior Notes 2019 Due 2027 [Member]", "terseLabel": "1.125% Senior Notes due 2027" } } }, "localname": "SeniorNotes2019Due2027Member", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20311.00PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]", "label": "Senior Notes 2019 Due 2031, 1.00 Percent [Member]", "terseLabel": "1.00% Senior Notes due 2031" } } }, "localname": "SeniorNotes2019Due20311.00PercentMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20311.625PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]", "label": "Senior Notes 2019 Due 2031, 1.625 Percent [Member]", "terseLabel": "1.625% Senior Notes due 2031" } } }, "localname": "SeniorNotes2019Due20311.625PercentMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20391.50PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]", "label": "Senior Notes 2019 Due 2039, 1.50 Percent [Member]", "terseLabel": "1.50% Senior Notes due 2039" } } }, "localname": "SeniorNotes2019Due20391.50PercentMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due20392.250PercentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]", "label": "Senior Notes 2019 Due 2039, 2.250 Percent [Member]", "terseLabel": "2.250% Senior Notes due 2039" } } }, "localname": "SeniorNotes2019Due20392.250PercentMember", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "mdt_SeniorNotes2019Due2049Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Notes 2019 Due 2049 [Member]", "label": "Senior Notes 2019 Due 2049 [Member]", "terseLabel": "1.75% Senior Notes due 2049" } } }, "localname": "SeniorNotes2019Due2049Member", "nsuri": "http://www.medtronic.com/20200901", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Ordinary shares, par value $0.0001 per share" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medtronic.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001613103-20-000029-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001613103-20-000029-xbrl.zip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